OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected to start before the end of Hilary Term to allow all future events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed on the Staff Gateway and via email to identified OxTalks users.
If you have any questions, please contact halo@digital.ox.ac.uk
Iosifina Foskolou, PhD, is a group leader at Sanquin Institute (Amsterdam), specialising in T cell metabolism and cancer immunotherapy. Her lab focuses on improving T cell immunotherapies against solid tumours by better understanding the environments immune cells face in both the tumour microenvironment and lymphoid tissues.
Iosifina holds a DPhil in Oncology from the University of Oxford, where she studied the effects of low oxygen (hypoxia) in solid tumours. She has extensive postdoctoral experience at both Cambridge University and the Karolinska Institute, where she investigated how metabolism can improve cancer immunotherapy.
Iosifina has a robust academic background, and her work has been widely published in peer-reviewed journals, with key papers on T cell function, metabolism, and anti-tumour immunity. Throughout her career, she has secured numerous grants, including a Marie Sklodowska Curie post-doctoral Fellowship.
